You are viewing the site in preview mode

Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma

  • 1,
  • 1,
  • 1,
  • 2,
  • 3,
  • 2,
  • 2,
  • 2,
  • 2,
  • 4,
  • 4,
  • 4,
  • 4,
  • 4,
  • 2, 3, 6,
  • 4,
  • 5,
  • 5,
  • 1, 4,
  • 6,
  • 2 and
  • 1, 4Email author
Contributed equally
Journal for ImmunoTherapy of Cancer20164:74

https://doi.org/10.1186/s40425-016-0181-6

  • Received: 24 October 2016
  • Accepted: 25 October 2016
  • Published:

The original article was published in Journal for ImmunoTherapy of Cancer 2016 4:28

Erratum

Unfortunately, after publication of this article [1], it was noticed that a funding source was not mentioned. Bristol-Myers Squibb was intended to be included in the ‘Financial Support’ section of the article.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
The Johns Hopkins University School of Medicine, Baltimore, USA
(2)
Department of Oncology, Baltimore, USA
(3)
Department Radiation Oncology, Baltimore, USA
(4)
Department of Neurosurgery, The Johns Hopkins University School of Medicine, 600 N. Wolfe St. Phipps Building Rm 123, Baltimore, 21287, MD, USA
(5)
Bristol-Myers Squibb Company, San Francisco, CA, USA
(6)
The Brady Urological Institute, Baltimore, USA

Reference

  1. Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunothera Cancer. 2016;4:28. doi:10.1186/s40425-016-0132-2.View ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement